February 27, 2015
by MMJ Publisher
Source: PharmaCan Capital Corp. Press Release
TORONTO, ONTARIO–(Marketwired – Feb. 27, 2015) -
PharmaCan Capital Corp. (TSX VENTURE:MJN) (“PharmaCan”) is pleased to announce that The Whistler Medical Marijuana Company (“WMMC”) has received notice from Health Canada confirming the renewal of its Marihuana for Medical Purposes Regulation (“MMPR”) license. PharmaCan has a 21.4% ownership interest in WMMC.
“This is another in a series of incredible milestones for WMMC. Following on the heels of receiving approval from Health Canada to begin producing in three new production rooms in December 2014, this renewal positions WMMC for an incredibly bright future as an integral supplier of medicine under Canada’s MMPR program.” said Paul Rosen, PharmaCan’s President and CEO. Mr. Rosen added that “The unique Whistler brand is already recognized globally, and we are confident that WMMC will become one of the most recognized and respected companies in our emerging industry. 2015 is shaping up to be an incredible year of growth and opportunity for the Whistler Medical Marijuana Company.”
Mr. Rosen continued “Today is a hallmark day for PharmaCan, and its investee companies. With license renewals this week at both Whistler Medical Marijuana and In the Zone, we feel more confident than ever that PharmaCan is building towards creating the most durable income stream generated from the sale of medical marihuana in Canada.”
About PharmaCan Capital Corp.
PharmaCan is a company in the business of investing in companies either licensed, or actively seeking a license, to produce medical marihuana pursuant to Canada’s MMPR. PharmaCan has a diversified portfolio of investments including investments in 5 of the 25 companies licensed by Heath Canada to produce medical marihuana.
About Whistler Medical Marijuana
WMMC, based in Whistler, British Columbia, received its original MMPR license in February 2014. The Fraser Valley Organic Producers Association certifies WMMC as organic. WMMC currently operates out of a 12,500 square foot facility that it owns. It has negotiated an option to purchase the remainder of the units in its building, which when exercised upon, would increase the total facility size to 33,000 square feet. PharmaCan has a 21.4% ownership interest in WMMC.
Recent CRON News
- Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders • GlobeNewswire Inc. • 04/26/2024 08:45:00 PM
- Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024 • GlobeNewswire Inc. • 04/25/2024 08:15:00 PM
- Marijuana Stocks Up After Banking Reform Progress • IH Market News • 04/09/2024 10:05:42 AM
- Cronos Launches Lord Jones® Chocolate Fusions • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Cronos Group Inc. to Speak at the 36th Annual Roth Conference • GlobeNewswire Inc. • 03/12/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:24:53 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/05/2024 10:21:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:17:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:15:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:13:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:09:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 09:16:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 01:06:27 PM
- Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹ • GlobeNewswire Inc. • 02/29/2024 01:05:00 PM
- U.S. Futures Dip as PCE Data Looms; Modest Gains for WTI and Brent Crude in April Contracts • IH Market News • 02/29/2024 11:13:07 AM
- Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024 • GlobeNewswire Inc. • 02/14/2024 09:15:00 PM
- Cronos’ Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1 • GlobeNewswire Inc. • 01/25/2024 12:00:00 PM
- Cronos Enters Australian Cannabis Market • GlobeNewswire Inc. • 01/09/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:04:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:03:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 10:12:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 10:10:39 PM
- Premium Cannabis Brand Lord Jones® Launches Live Resin Vapes • GlobeNewswire Inc. • 12/15/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 12:34:54 PM
- Cronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facility • GlobeNewswire Inc. • 11/27/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM